Aspen Aerogels (ASPN) Cost of Revenue (2013 - 2026)

Aspen Aerogels (ASPN) has 14 years of Cost of Revenue data on file, last reported at $6.7 million in Q1 2026.

• For the quarter ending Q1 2026, Cost of Revenue fell 88.07% year-over-year to $6.7 million; the trailing twelve-month figure through Mar 2026 stood at $72.1 million (down 13.37% YoY), and the FY2025 full-year result was $28.2 million, down 20.96% from the prior year.
• Cost of Revenue for Q1 2026 stood at $6.7 million, up from $6.3 million in the prior quarter.
• Across five years, Cost of Revenue topped out at $154.4 million in Q4 2022 and bottomed at $6.3 million in Q4 2025.
• The 5-year median for Cost of Revenue is $9.5 million (2024), against an average of $34.2 million.
• The widest annual swing landed in 2022, when Cost of Revenue surged 1213.09%; it then plunged 88.07% in 2026.
• A 5-year view of Cost of Revenue shows it stood at $154.4 million in 2022, then plunged by 64.65% to $54.6 million in 2023, then sank by 84.35% to $8.5 million in 2024, then dropped by 26.11% to $6.3 million in 2025, then rose by 5.59% to $6.7 million in 2026.
• The last three Cost of Revenue figures came in at $6.7 million (Q1 2026), $6.3 million (Q4 2025), and $52.2 million (Q3 2025), per Business Quant data.

Peer Comparison